Condition
Von Willebrand Disease, Type 3 clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Von Willebrand Disease, Type 3 clinical trials that are recruiting, at sites in 14 countries (most in United States (2), Belgium (1), Canada (1)). By phase: Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 14Countries
All recruiting trials (2)
-
Emicizumab prophylaxis for people with Type 3 von Willebrand disease
This trial will test whether regular emicizumab injections reduce bleeds compared with on-demand standard therapy for people aged 1 month and older with Type 3 von Willebrand disease, while also studying people already on prophylaxis using their prior data.
-
Emicizumab treatment for severe Von Willebrand Disease and Hemophilia A
This study is testing if a new injection called Emicizumab can help people with severe Von Willebrand Disease or both Von Willebrand Disease and Hemophilia A prevent serious bleeding better than current treatments.
Related topics
Quick answers
How many Von Willebrand Disease, Type 3 clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in United States (2 trials), Belgium (1 trial), Canada (1 trial), Colombia (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.